April 3 (Reuters) - Kintara Therapeutics Inc ( KTRA ):

* KINTARA THERAPEUTICS AND TUHURA BIOSCIENCES ENTER INTO

DEFINITIVE MERGER AGREEMENT

* KINTARA THERAPEUTICS INC ( KTRA ) - $31 MILLION SUBSCRIBED

FINANCING BY

TUHURA IN CONNECTION WITH MERGER AGREEMENT EXPECTED TO PROVIDE

CASH RUNWAY INTO LATE 2025

* KINTARA THERAPEUTICS INC ( KTRA ) - COMBINED COMPANY IS EXPECTED TO

OPERATE UNDER NAME "TUHURA BIOSCIENCES, INC."

* KINTARA THERAPEUTICS ( KTRA ) - ON A PRO FORMA BASIS, POST-MERGER

CO'S

EQUITYHOLDERS EXPECTED TO COLLECTIVELY OWN UP TO ABOUT 2.85%, OR

APPROXIMATELY 5.45%

* KINTARA THERAPEUTICS INC ( KTRA ) - TUHURA EQUITYHOLDERS ARE

EXPECTED TO

COLLECTIVELY OWN APPROXIMATELY 97.15%, OR 94.55% ASSUMING

DISTRIBUTION OF CVR SHARES

* KINTARA THERAPEUTICS INC ( KTRA ) -COMBINED COMPANY IS EXPECTED TO

TRADE

ON NASDAQ CAPITAL MARKET ("NASDAQ") UNDER TICKER "HURA"

Source text for Eikon:

Further company coverage: